Discovery Sprint · Advanced antibody immunoprofiling
Get decision-ready immune data from complex antibody responses
The ImmunoSig Discovery Sprint is a focused, fixed-scope immunoprofiling pilot for research teams that need to understand antibody specificity, antigen recognition and biological differences before committing to a larger study.From vaccines and infectious diseases to autoantibody research and biomarker discovery, we help turn complex antibody-binding data into clear, testable biological insights.
ImmunoSig Ltd is a company incorporated in
England and Wales.
Company No. 16642090, VAT No. GB 510 1556 40.
86-90 Paul Street, London, EC2A 4NE
© 2026 All rights reserved. ImmunoSig Ltd. Privacy Notice
The standard assay bottleneck
You may already know that an antibody response exists. The harder question is understanding what the response is recognising, how it differs between groups, and which signals actually matter.The Discovery Sprint can help determine:
Which antigens or epitopes are preferentially recognised
How antibody profiles differ between study groups
Which signals best distinguish biological phenotypes or conditions
How broad or cross-reactive the antibody response is
Which candidates should be prioritised for further investigation
Whether a larger study is scientifically justified
The aim is not simply to generate more data. It is to reduce uncertainty around your next research decision.
Detailed immune insights
The ImmunoSig Discovery Sprint combines peptide or protein microarrays (custom and off-the-shelf) with advanced statistical analysis and biological interpretation to investigate antibody specificity, cross-reactivity and antigen recognition.Instead of selecting targets based only on assumptions or individual measurements, you can explore antibody responses across many candidate antigens simultaneously and identify the signals most worth pursuing.
Typical questions we answer
Are antibody profiles different between cases and controls?
What distinguishes responders from non-responders?
Which antigens or epitopes show the strongest differential recognition?
Are there previously unrecognised autoantibody targets?
How broad or cross-reactive is the antibody response?
Can combinations of antibody signals distinguish biological groups?
Which candidates should move into validation?
Is a larger immunoprofiling study justified?
Could the data strengthen a grant application, publication or development programme?
What the Discovery Sprint includes
Initial scientific consultation and study-design review
Selection or design of a focused peptide or protein array
Comparison of defined study groups or experimental conditions
Quality-controlled antibody-binding dataset
Ranked antigen and epitope signals
Statistical and multivariate analysis
Machine-learning analysis where scientifically appropriate
Publication-ready visualisations
Biological interpretation of the strongest findings
Interpretation meeting and recommended next steps
One platform. Different biological questions.
The same high-dimensional antibody profiling approach can be applied across different areas of research.Vaccines & infectious diseases
Understand antigen recognition, response breadth, cross-reactivity and differences between immune responders.Autoimmunity & autoantibodies
Explore differential autoantibody recognition and identify candidate antigen signatures associated with disease or phenotype.Biomarker discovery
Identify combinations of antibody signals that distinguish cohorts, clinical groups or biological states.Antigen & epitope discovery
Prioritise proteins, domains or peptide sequences for validation and further development.
Why ImmunoSig?
Scientific depth, decision-focused delivery
ImmunoSig combines high-content antibody profiling with advanced biostatistics, multivariate analysis and machine learning.The objective is not simply to provide an array dataset. We work with you to determine which signals are biologically meaningful, what they imply, and what should happen next.
Founded by scientists with deep experience in antibody characterisation, vaccine development and protein microarray technology
Experience spanning custom protein and peptide microarrays and complex immunological datasets
Platform experience applied in research involving organisations including the University of Oxford, GSK, NIH, FDA and Wellcome-linked programmes
Peer-reviewed research published in Nature Communications, PLoS Pathogens, Vaccine, Journal of Infectious Diseases and mBio
Analysis designed around biological interpretation rather than simple signal ranking
Decision-ready outputs including antigen prioritisation, cohort comparisons, multivariate signatures and recommended next experiments
Start the Discovery Sprint conversation
You do not need a fully designed experiment before contacting us.Tell us the biological question you are trying to answer, what samples you have available and what you already know.We will advise whether a Discovery Sprint is the right starting point and how we would approach the study.
Thank you
Thank you for your message. We aim to reply within 24 hours.
Privacy notice
ImmunoSig Ltd respects your privacy. When you contact us, submit an enquiry or use this website, we may collect your contact details, information about your enquiry and limited technical information about your use of the website.We use this information to respond to enquiries, provide requested services, operate and improve our website, maintain business records and comply with legal or regulatory obligations.We do not sell personal data. We may share it with trusted service providers that support our website, communications, analytics, IT systems and professional services, or with regulators and authorities where required by law. These organisations are required to protect personal data appropriately.Our full Privacy Notice explains the lawful bases we rely on, how long we retain information, any international transfers, your rights under UK data protection law and how to contact us or raise a complaint.